Detection of Alzheimer’s and Parkinson’s disease from exhaled breath using nanomaterial-based sensors

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Brookmeyer R, Johnson E, ZieglerGraham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimer’s Dement.3(3),186–191 (2007).▪▪ Excellent review on Alzheimer’s disease.
  MedlineGoogle Scholar
• 2  De Rijk MC, Launer LJ, Berger K et al. Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurology54(11 Suppl. 5),S21–S23 (2000).
  Medline CASGoogle Scholar
• 3  Hu WT, Chen-Plotkin A, Arnold SE et al. Biomarker discovery for Alzheimer’s disease, frontotemporal lobar degeneration, and Parkinson’s disease. Acta Neuropathol.120(3),385–399(2010).▪▪ Reviews recent research in the field of Alzheimer’s and Parkinson’s disease biomarkers.
  MedlineGoogle Scholar
• 4  Elman LB, Houghton DJ, Wu GF, Hurtig HI, Markowitz CE, Mccluskey L. Palliative care in amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis. J. Palliat. Med.10(2),433–457 (2007).
  MedlineGoogle Scholar
• 5  Ewers M, Mielke MM, Hampel H. Blood-based biomarkers of microvascular pathology in Alzheimer’s disease. Exp. Gerontol.45(1),75–79 (2010).
  Medline CASGoogle Scholar
• 6  Lozano AM, Kalia SK. New movement in Parkinson’s. Sci. Am.293(1),68–75 (2005).▪▪ Excellent review on Parkinson’s disease.
  MedlineGoogle Scholar
• 7  Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol.56(1),33–39 (1999).
  Medline CASGoogle Scholar
• 8  Braak H, Del Tredici K, Rub U, De Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging24(2),197–211 (2003).
  MedlineGoogle Scholar
• 9  Houghton DJ, Hurtig HI. Movement disorders. In: The Encyclopedia of Life Sciences. John Wiley & Sons, Ltd, Chichester, UK (2009).
  Google Scholar
• 10  De Meyer G, Shapiro F, Vanderstichele H et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch. Neurol.67(8),949–956 (2010).
  MedlineGoogle Scholar
• 11  Barba I, Fernandez-Montesinos R, Garcia-Dorado D, Pozo D. Alzheimer’s disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics. J. Cell. Mol. Med.12(5A),1477–1485 (2008).
  Medline CASGoogle Scholar
• 12  Michell AW, Mosedale D, Grainger JD, Barker RA. Metabolomic analysis of urine and serum in Parkinson’s disease. Metabolomics4,191–201 (2008).
  CASGoogle Scholar
• 13  Ahmed SS, Santosh W, Kumar S, Christlet HTT. Metabolic profiling of Parkinson’s disease: evidence of biomarker from gene expression analysis and rapid neural network detection. J. Biomed. Sci.16,63 (2009).
  MedlineGoogle Scholar
• 14  Bogdanov M, Matson WR, Wang L et al. Metabolomic profiling to develop blood biomarkers for Parkinson’s disease. Brain131(Pt 2),389–396 (2008).
  MedlineGoogle Scholar
• 15  Quinones MP, Kaddurah-Daouk R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol. Dis.35(2),165–176 (2009).
  Medline CASGoogle Scholar
• 16  Greenberg N, Grassan A, Thambisetty M, Lovestone S, Legido-Quigley C. A proposed metabolic strategy for monitoring disease progression in Alzheimer’s disease. Electrophoresis30,1235–1239 (2009).
  Medline CASGoogle Scholar
• 17  Ohrfelt A, Grognet P, Andreasen N et al. Cerebrospinal fluid α-synuclein in neurodegenerative disorders-a marker of synapse loss? Neurosci. Lett.450(3),332–335 (2009).
  MedlineGoogle Scholar
• 18  Songa G, Qina T, Liua H et al. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer67,227–231 (2010).
  MedlineGoogle Scholar
• 19  De Gennaro G, Dragonieri S, Longobardi F et al. Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure. Anal. Bioanal. Chem.398(7–8),3043–3050 (2010).
  Medline CASGoogle Scholar
• 20  Tisch U, Haick H. Arrays of chemisensitive monolayer-capped metallic nanoparticles for diagnostic breath testing. Rev. Chem. Eng.26,171–179 (2011).
  Google Scholar
• 21  Peng G, Hakim M, Broza YY et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br. J. Cancer103,542–551 (2010).▪ Presents a gold nanoparticle sensor array to discriminate between breath patterns of healthy states and the four most widespread cancers in the developed world.
  Medline CASGoogle Scholar
• 22  Ionescu R, Broza Y, Shaltieli H et al. Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes. ACS Chem. Neurosci.2,687–693 (2011).▪▪ Presents the detailed characterization of organically functionalized carbon nanotube sensors and their application to breath analysis for identifying a neurodegenerative disease. The same types of sensors were used in the current study.
  Medline CASGoogle Scholar
• 23  Haick H. Chemical sensors based on molecularly modified metallic nanoparticles. J. Phys. D.40,7173–7186 (2007).
  CASGoogle Scholar
• 24  Punyadeera C, Van Der Merwe MT, Crowther NJ et al. Weight-related differences in glucose metabolism and free fatty acid production in two South African population groups. Int. J. Obes. Relat. Metab. Disord.25(8),1196–1205 (2001).
  Medline CASGoogle Scholar
• 25  Punyadeera C, Van Der Merwe MT, Crowther NJ, Toman M, Schlaphoff GP, Gray IP. Ethnic differences in lipid metabolism in two groups of obese South African women. J. Lipid Res.42(5),760–767 (2001).
  Medline CASGoogle Scholar
• 26  Haick H, Hakim M, Patrascu M et al. Sniffing chronic renal failure in rat model by an array of random networks of single-walled carbon nanotubes. ACS Nano3(5),1258–1266 (2009).
  Medline CASGoogle Scholar
• 27  Marom O, Nakhoul F, Tisch U, Shiban A, Abassi Z, Haick H. Gold nanoparticle sensors for detecting chronic kidney disease and disease progression. Nanomedicine (Lond.)7(5),639–650 (2012).
  CASGoogle Scholar
• 28  Peng G, Tisch U, Adams U et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat. Nanotechnol.4(10),669–673 (2009).
  Medline CASGoogle Scholar
• 29  Shuster G, Gallimidi Z, Reiss AH et al. Classification of breast cancer precursors through exhaled breath. Breast Cancer Res. Treat.126,791–796 (2010).
  MedlineGoogle Scholar
• 30  Hakim M, Billan S, Tisch U et al. Diagnosis of head-and-neck cancer from exhaled breath. Br. J. Cancer104,1649–1655 (2011).
  Medline CASGoogle Scholar
• 31  Barash O, Peled N, Hirsch FR, Haick H. Sniffing the unique ‘odor print’ of non-small-cell lung cancer with gold nanoparticles. Small5(22),2618–2624 (2009).
  Medline CASGoogle Scholar
• 32  Tisch U, Aluf Y, Ionescu R et al. Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors. ACS Chem. Neurosci.3(3),161–166 (2012).▪▪ Reports the detection of presymptomatic nigrostriatal dopaminergic lesion in rats through breath analysis, using carbon nanotube sensors. The same type of sensors were used in the present study.
  Medline CASGoogle Scholar
• 33  Tisch U, Haick H. Nanomaterials for cross-reactive sensor arrays. MRS Bull.35(10),797–803 (2010).▪▪ Discusses the application of nanomaterialbased sensors for breath testing.
  CASGoogle Scholar
• 34  Miller A, Avidan N, Tzunz-Henig N et al. Translation towards personalized medicine in multiple sclerosis. J. Neurol. Sci.274(1–2),68–75 (2008).
  MedlineGoogle Scholar
• 35  Peng G, Trock E, Haick H. Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with nonpolymeric organic materials. Nano Lett.8(11),3631–3635 (2008).
  Medline CASGoogle Scholar
• 36  Peng G, Tisch U, Haick H. Detection of nonpolar molecules by means of carrier scattering in random networks of carbon nanotubes: toward diagnosis of diseases via breath samples. Nano Lett.9,1362–1368 (2009).
  Medline CASGoogle Scholar
• 37  Amann A, Miekisch W, Pleil J, Risby T, Schubert J. Chapter 7: Methodological issues of sample collection and analysis of exhaled breath. Eur. Res. Soc. Monograph49,96–114 (2010).▪▪ Detailed review of state-of-the-art methods for breath sample collection and breath analysis. Discusses the future potential of the method for medical diagnostics and proposes standardization.
  Google Scholar
• 38  Zilberman Y, Tisch U, Shuster G et al. Carbon nanotube/hexa-peri-hexabenzocoronene bilayers for discrimination between nonpolar volatile organic compounds of cancer and humid atmospheres. Adv. Mater.22,4317–4320 (2010).
  Medline CASGoogle Scholar
• 39  Zilberman Y, Ionescu R, Feng X, Müllen K, Haick H. Nanoarray of polycyclic aromatic hydrocarbons and carbon nanotubes for accurate and predictive detection in real-world environmental humidity. ACS Nano5(8),6743–6753 (2011).
  Medline CASGoogle Scholar
• 40  Konvalina G, Haick H. Effect of humidity on nanoparticle-based chemiresistors: a comparison between synthetic and real-world samples. ACS Appl. Mater. Interfaces4(1),317–325 (2012).▪▪ Presents a detailed characterization of organically functionalized gold nanoparticle sensors and their application to breath analysis. The same types of sensors were used in the current study.
  Medline CASGoogle Scholar
• 41  Tisch U, Haick H. Sensors based on monolayer-capped metal nanoparticles. In: Chemical Sensors – Vol. 2: Nanstructured Materials. Korotcenkov G (Ed.). Momentum Press, LLC, NY, USA, 141–202 (2010).
  Google Scholar
• 42  Haick H, Hakim M, Patrascu M et al. Sniffing chronic renal failure in rat model by an array of random networks of single-walled carbon nanotubes. ACS Nano3,1258–1266 (2009).
  Medline CASGoogle Scholar
• 43  Na N, Zhang SC, Wang SA, Zhang XR. A catalytic nanomaterial-based optical chemo-sensor array. J. Am. Chem. Soc.128(45),14420–14421 (2006).
  Medline CASGoogle Scholar
• 44  Ionescu R, Llobet E, Vilanova X et al. Quantitative analysis of NO₂ in the presence of CO using a single tungsten oxide semiconductor sensor and dynamic signal processing. Analyst127,1237–1246 (2002).
  Medline CASGoogle Scholar
• 45  Brereton RG. Chemometrics, Application of Mathematics Statistics to Laboratory Systems. Ellis Horwood, Chichester, UK (1990).
  Google Scholar
• 46  Wilkoxon F. Individual comparisons by ranking methods. Biomet. Bull.1,80–83 (1945).
  Google Scholar
• 47  Buszewski B, Kesy M, Ligor T, Amann A. Human exhaled air analytics: biomarkers of diseases. Biomed. Chromatogr.21(6),553–566 (2007).▪ Excellent review of breath biomarkers of different diseases and of confounding breath compounds.
  Medline CASGoogle Scholar
• 48  Hughes AJ, Daniel SE, Ben Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain125,861–870 (2002).
  MedlineGoogle Scholar
• 49  Jiang D, Li X, Williams R et al. Ternary complexes of iron, amyloid-b, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer’s disease. Biochemistry (Mosc.).48(33),7939–7947 (2009).
  Medline CASGoogle Scholar
• 50  Aluf Y, Vaya J, Khatib S, Finberg JP. Alterations in striatal oxidative stress level produced by pharmacological manipulation of dopamine as shown by a novel synthetic marker molecule. Neuropharmacology61(1–2),87–94 (2011).
  Medline CASGoogle Scholar
• 51  Aluf Y, Vaya J, Khatib S, Loboda Y, Kizhner S, Finberg JP. Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule. Free Radic. Res.44(6),635–644 (2010).
  Medline CASGoogle Scholar